SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009720
Filing Date
2020-08-06
Accepted
2020-08-06 17:14:09
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20200630x10q.htm   iXBRL 10-Q 1397288
2 EX-31.1 tmb-20200630xex31d1.htm EX-31.1 13729
3 EX-31.2 tmb-20200630xex31d2.htm EX-31.2 13882
4 EX-32.1 tmb-20200630xex32d1.htm EX-32.1 7707
5 GRAPHIC tmb-20200630x10q004.jpg GRAPHIC 6941
6 GRAPHIC tmb-20200630x10q007.jpg GRAPHIC 53528
  Complete submission text file 0001558370-20-009720.txt   4363845

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20200630.xsd EX-101.SCH 23634
8 EX-101.CAL tmb-20200630_cal.xml EX-101.CAL 38980
9 EX-101.DEF tmb-20200630_def.xml EX-101.DEF 96809
10 EX-101.LAB tmb-20200630_lab.xml EX-101.LAB 284893
11 EX-101.PRE tmb-20200630_pre.xml EX-101.PRE 195043
12 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200630x10q_htm.xml XML 557250
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 201082743
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences